Surrozen Inc. (NASDAQ: SRZN)
$9.25
-0.0773 ( -0.83% ) 3.8K
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Market Data
Open
$9.25
Previous close
$9.33
Volume
3.8K
Market cap
$30.71M
Day range
$9.05 - $9.67
52 week range
$4.50 - $16.19
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 11, 2023 |
8-k | 8K-related | 14 | Nov 08, 2023 |
10-q | Quarterly Reports | 72 | Nov 08, 2023 |
def | Proxies and info statements | 5 | Oct 24, 2023 |
pre | Proxies and info statements | 5 | Oct 13, 2023 |
8-k | 8K-related | 14 | Oct 13, 2023 |
3 | Insider transactions | 2 | Aug 23, 2023 |
10-q | Quarterly Reports | 69 | Aug 09, 2023 |
8-k | 8K-related | 14 | Aug 09, 2023 |
8-k | 8K-related | 15 | Jul 19, 2023 |